As a shareholder of the company, we will see some profits, but nowhere what we should. I think the reason they're holding back the numbers, is because they're very good. Remember this is company with no debt and ridiculous cash flows. Dr. Leatt is the only one who is going to get really rich on this deal.
He owns the rights to the patent, just like you said.